AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

J.P. Morgan analyst Seiji Wakao maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) on March 5 and set a price target of Yen4,600.00. The company’s shares closed ...

Scientists studying how cancers spread have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response. In their mouse study, aspirin helped ...

Share on Pinterest Research in mice shows how aspirin may boost the immune response against cancer, keeping secondary tumors at bay. Image credit: AsiaVision/Getty Images. Around half of all ...

Various measures of abnormal left atrial (LA) structure or function (LA myopathy) are associated with a higher risk of ischemic stroke and dementia, independent of atrial fibrillation. However, ...

Feb 28 (Reuters) - The European Union's health regulator on Friday backed AstraZeneca (AZN.L), opens new tab and Daiichi Sankyo's (4568.T), opens new tab drug Enhertu as a breast cancer treatment ...

In this video, Michael Cecchini, MD, discussed data from the ALASCCA trial, which followed patients with colorectal cancer who were treated with a large dose of aspirin. The large randomized ...

New guidelines advise against daily low-dose aspirin for healthy older adults due to the risk of gastrointestinal bleeding outweighing the benefits, yet many Americans still follow the outdated advice ...